People with limited education and low income have higher odds of death within 30 days after undergoing an operation for lung cancer than those who…

Researchers at Genes and Cancer group at Bellvitge Biomedical Research Institute (IDIBELL), led by Montse Sanchez-Cespedes, have identified the PARD3 gene as a tumor suppressor that is…

Since November 2014 nintedanib (trade name: Vargatef) has been approved in combination with docetaxel for the treatment of adults with advanced non-small cell lung cancer (NSCLC) of…

The Women’s Health Initiative Studies, a large prospective study of lung cancer, found no strong associations between lung cancer risk and a…

Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000…

The German Lung Cancer Screening Intervention Trial (LUSI) shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second…

Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. For example, nanoparticles can be engineered to be able to transport medicines specifically to…

An analysis of lung cancer incidence and screening found a decline in the proportion of patients with lung cancer meeting high-risk screening criteria, suggesting that an increasing…

New research from Johns Hopkins School of Medicine reveals a high value of scans which could lead to future change of reimbursement policies for follow-up…

U.S. health regulators on Thursday approved Medicare coverage for lung cancer screening by low-dose CT, the first time the government health insurance program for the elderly and disabled will…

A new analysis led by researchers at the American Cancer Society in collaboration with the International Agency for Research on Cancer (IARC) finds lung…

Adding head and neck cancer screenings to recommended lung cancer screenings would likely improve early detection and survival, according to a multidisciplinary team led…

CANCER RESEARCH UK scientists have taken microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells - meaning they can break loose and…

University of Cincinnati researchers have found in a phase-2 clinical trial that a Food and Drug Administration-approved therapy could be effective in treating both older and African…

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those…

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer…

Scientists have shown how a lung cancer patient’s blood sample could be used to monitor and predict their response to treatment - paving the way for personalised medicine…

Bristol-Myers Squibb Co on Tuesday said it plans this year to begin a late-stage trial testing whether a combination of two of its high-profile immunotherapies can effectively treat…

Scientists from The University of Manchester – part of the Manchester Cancer Research Centre (MCRC) - have discovered a new protein that is involved in cancer and inflammation in…

A University of Colorado Cancer Center study published in the journal PLoS ONE shows that bladder and lung cancers are marked by shared differences in the genetics that control…

It’s common knowledge that smoking causes lung cancer. But what many Americans don’t know is that one in five women who will contract lung cancer this year in…

Lung cancer kills more Canadians each year than any other malignancy, but a national advocacy organization says the disease is an under-addressed…

Treating aggressive lung cancer with the diabetes drug metformin along with radiation and chemotherapy may slow tumor growth and recurrence, suggests new preliminary…

The investigational drug AZD9291, a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to…

PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities…